Review

Nature Reviews Cancer 5, 275-284 (April 2005) | doi:10.1038/nrc1590

Tumour stem cells and drug resistance

Michael Dean1, Tito Fojo2 & Susan Bates2  About the authors

Top

The contribution of tumorigenic stem cells to haematopoietic cancers has been established for some time, and cells possessing stem-cell properties have been described in several solid tumours. Although chemotherapy kills most cells in a tumour, it is believed to leave tumour stem cells behind, which might be an important mechanism of resistance. For example, the ATP-binding cassette (ABC) drug transporters have been shown to protect cancer stem cells from chemotherapeutic agents. Gaining a better insight into the mechanisms of stem-cell resistance to chemotherapy might therefore lead to new therapeutic targets and better anticancer strategies.

Author affiliations

  1. Laboratory of Genomic Diversity, National Cancer Institute-Frederick, Frederick, Maryland 21702, USA.
  2. Cancer Therapeutics Branch, National Cancer Institute, Bethesda, Maryland, 20892, USA.

Correspondence to: Michael Dean1 Email: dean@ncifcrf.gov

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Casting back to stem cells

Nature Cell Biology News and Views (01 Feb 2009)

Extra navigation

Subscribe

Subscribe to Nature Reviews Cancer

Search PubMed for

naturejobs

Advertisement